University of California San Francisco
Give to UCSF
Two demonstration projects that aim to yield quick results for patients have been selected by the new California Initiative to Advance Precision Medicine, a public-private effort launched by Governor Edmund G. Brown Jr.
In a project spearheaded by investigators at UCSF, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
A blood-borne molecule that increases in abundance as we age blocks regeneration of brain cells and promotes cognitive decline, suggests a new study.
UC San Francisco scientists have identified characteristics of a family of daughter cells, called MPPs, which are the first to arise from stem cells within bone marrow that generate the entire blood system.
Oncologists are treating the immune system instead of tumors to fight cancer – with startling results.
A team led by researchers from UCSF, Organic Health Response and Microclinic International is reporting results of a study that showed significant benefits of microclinics – an innovative intervention that mobilized rural Kenyan HIV patients’ informal social networks to support their staying in care.
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia, the most common type of childhood cancer.
A research team led by scientists from UCSF, Baylor College of Medicine, and Texas Children’s Hospital has identified a new autoimmune syndrome characterized by a combination of severe lung disease and arthritis that currently has no therapy.
Immune cells perform a previously unsuspected role in the brain that may contribute to obesity, according to a new study by UCSF researchers.
UCSF is among the top universities in the world yet again, ranking among the top five in seven subject areas, according to the inaugural U.S. News & World Report Best Global Universities report.
Scores of autoimmune diseases mysteriously cause the immune system to harm tissues within our own bodies. Now, a new study pinpoints the complex genetic origins for many of these diseases.
A newly discovered population of immune cells in tumors is associated with less severe cancer outcomes in humans, and may have therapeutic potential, according to a new UCSF study.
A scientific team led by UCSF researchers found that regulatory T cells, a specialized subset of immune cells, suppress inflammation and muscle injury in a mouse model of Duchenne muscular dystrophy.
Children who repeatedly become infected with malaria often experience no clinical symptoms with these subsequent infections, and a team led by UC San Francisco researchers has discovered that this might be due at least in part to a depletion of specific types of immune cells.
The second round of funding opportunities for the Technology Development Award from the University of California Center for Accelerated Innovation (UC CAI) has begun.
